If patients with rheumatoid arthritis (RA) could self-report symptoms in a manner which correlated with laboratory measures of inflammation this would be a valuable research or clinical tool. Developing such a tool means ensuring that the questions are understood and a variety of combinations of signs, symptoms and joints explored. Preliminary studies in two groups of 20 RA out-patients established an acceptable self-report questionnaire format by which patients could identify their joints. Fifty RA out-patients completed these self-report forms on four grades of each of four symptoms (pain, heat, stiffness, swelling) in each of 64 joints, as well as visual analogue scales (VAS) on overall pain and perceived disease activity. A clinical research assistant recorded the Thompson-Kirwan articular index (TKAI) and plasma viscosity (PV) was measured. The data were analysed in a variety of ways in an attempt to construct a self-report articular index (SRAI) which correlated with PV. The strongest models were then tested in 11 in-patients undergoing a flare of their disease. No adequate SRAI could be constructed which correlated with PV and in addition neither VAS score correlated with PV. There was a moderate correlation between the TKAI and a patient SRAI using the same joints, symptoms and weightings (r = 0.6, P < 0.01). Patients can clearly report different grades of multiple symptoms in multiple joints, but such reports cannot be shown to be a reliable indicator of inflammatory activity.
IN rheumatoid arthritis (RA) some means of assessing inflammatory activity is necessary in order to evaluate disease progression, efficacy of therapy and treatment strategies. The criteria for assessing such inflammatory activity vary, but usually include a combination of clinical assessments (e.g. examination of joints for synovitis and tenderness), laboratory indices of inflammation [e.g. C-reactive protein (CRP), plasma viscosity] and patient reports of symptoms (e.g. pain, stiffness and fatigue) [1] .
These traditional assessments, essential for patient management, require the patient to make a hospital visit for clinical examination and/or venepuncture. However, in some research studies (e.g. psychological projects) such visits are an unnecessary inconvenience as the patient could complete self-report questionnaires for the main part of the study and it is only the need for an assessment of inflammatory activity which demands a visit to the clinician. If patients could accurately report their own inflammatory activity such a requirement would be obviated. The development of a simple self-report questionnaire which reflected joint inflammation as measured by traditional methods would therefore be a valuable research tool for use in studies where it was required for research rather than management purposes. Such a non-invasive self-report measure would save both time and inconvenience for the patient and the researcher. Indeed it may be that patients are better able to assess their inflammatory activity than health care professionals and patients may also be more sensitive to minor changes in their own feelings and symptoms.
Standardized methods for health care professionals to assess and record joint symptoms and signs (articular indices) relate to pain, tenderness, warmth and soft tissue swelling, all of which are clinical indications of joint inflammation. Articular indices (AI) include the Ritchie index [2] (based on graded tenderness in various joint groups), the American Rheumatism Association index [3] (based on the sum of tender or swollen joints in slightly different groups) and the Lansbury index [4] (based on graded inflammation in joints weighted for surface area). However, these are largely pain scores and do not correlate with the acute phase response [5] . Measures of joint inflammation which are to be used as an indicator of inflammatory activity should correlate with laboratory measures of inflammation such as CRP and plasma viscosity (PV). Therefore a more fundamental approach to the development of an AI was taken by Thompson et al. [5] who used computer analysis to identify the combination of signs, joints and grading of symptoms that was most efficient at summarizing overall inflammation by correlation with CRP. This Thompson-Kirwan AI (TKAI) records the presence or absence of soft-tissue swelling/effusion plus tenderness on firm pressure in selected joints weighted for size.
Mason et al. have developed a self-report questionnaire (RADAR) which incorporates a self-report AI but the resultant four-page questionnaire was not validated against laboratory measures of inflammatory activity [6] . Stewart et al. [7] attempted to show that the TKAI is a reliable measure of inflammatory activity when completed by patients. Whilst self-reported TKAI correlated well with clinician TKAI, it did not correlate with CRP. However, the TKAI was designed specifically as a measure of health care professionals' ability to assess joint inflammation clinically and relies on their skills in eliciting the presence of soft tissue swelling and the ability to apply pressure over the joint margins.
If they are to adequately assess their own inflammatory activity, patients may require an AI with a different internal structure, for example concentrating on different symptoms or joints or using a different method of grading. In order to devise and validate a reliable self-report AI (SRAI) it is therefore necessary to approach it in the same manner as was used for developing the TKAI, rather than assume that any existing index is the most appropriate. The aim of the study therefore was to develop an SRAI which correlated with the acute phase response.
However, to do so requires the collection of numerous data (grades of multiple symptoms in multiple joints) and patients may find such a questionnaire incomprehensible or unacceptable. The first steps were therefore to design an easily understood questionnaire format and then to establish whether or not patients can correctly identify their joints, a pre-requisite before any SRAI can be tested and validated. At the same time simple visual analogue scales (VAS) of pain and perceived 'disease activity' were assessed lest these alone might suffice for patients to adequately self-report inflammatory activity.
PATIENTS AND METHODS
Studies were initially conducted in out-patients with classical RA [8] who were recruited whilst awaiting their out-patient consultation, with the final study being conducted on in-patients admitted during a flare of their RA.
Data collection centred on self-reported graded symptoms (0-3) of pain, heat, stiffness and swelling in 64 joints. These joints included left and right temporomandibular joints, neck, shoulders, elbows, wrists, metacarpal phalangeal joints 1-5 (MCPs), proximal interphalangeal joints 2-5 (PIPs), distal interphalangeal joints 2-5 (DIPs), thumb interphalangeal joint (IP), hips, knees, ankles, metatarsal phalangeal joints 1-5 (MTPs), great toe interphalangeal joint (IP) and combined proximal and distal interphalangeal joints 2-5 (toes) (IPs).
Study 1 was designed to establish a questionnaire format for this necessarily complex data set, which patients could understand and complete without error. Twenty patients with RA were asked to report the symptom of pain using a questionnaire laid out in three different formats, which were given in random order. Format A comprised a list of joints each accompanied by the numbers 0, 1, 2 and 3 to indicate grade of pain. Format B was a line drawn figure with blank circles around the joints, in which the patient should write the number to indicate the grade of symptom. Format C was an identical list to format A but was accompanied by a drawing showing labelled joints. On all formats lay terms were substituted for medical terms in the hands (knuckles for MCPs, middle joints for PIPs and end joints for DIPs) and feet (base of toes for MTPs, toe joints for IPs). After completion of all three formats each patient was asked which of the three forms they preferred.
Study 2 was designed to establish whether or not patients could identify their own joints correctly using either format A or B (C having being discarded on the results of the previous study). Ten out-patients with RA were given format A (the list) to complete and 10 format B (the figure). After they had completed the questionnaire, using the pain symptom only, their identification of every joint (whether symptomatic or not) was checked by a clinical research assistant.
Study 3 was performed using format A (the list) to collect the data for developing and validating the SRAI. Format A was chosen on the basis of the results from studies 1 and 2. Sixty-one out-patients with RA were invited to take part and 50 patients completed all the questionnaires. These included four grades for each of four symptoms for each of the 64 joints laid out in format A ( Fig. 1 ) and 10 cm VAS for pain and perceived disease activity. The question on perceived disease activity read 'How active has your arthritis been over the past 24 hours?' Patients were asked to complete all the questions in relation to symptoms present over the last 24 h only. Inflammatory activity was assessed by a clinical research assistant performing the TKAI and taking blood for CRP and PV estimation (one patient did not have PV measured). Data from the patients in study 3 were analysed in a variety of ways, both in univariate and multivariate analyses, in order to identify the combination of joints and symptoms which correlated most highly with measures of the acute phase response.
Finally, in study 4, 12 in-patients admitted during a flare of their RA were recruited in a similar manner and asked to complete the same data sets (11 patients completed all data sets).
RESULTS
In study 1 the lists, with or without accompanying pictures (formats A and Q were preferred by 50% of patients while 45% preferred the figure (format B) and 5% had no preference. As patients were comfortable with either the list or figure it was decided to eliminate format C (combined list/diagram) at this point as it added nothing extra.
In study 2, 91% of the 1280 joints were correctly identified using either questionnaire, indicating that either format A or B would be acceptable. The figure (format B) had the disadvantage of requiring a separate diagram to be completed for each of the four symptoms (i.e. four sheets of paper) and so it was decided to use the list (format A) which could conveniently fit onto two sides of paper, one for each of the left and right sides of the body (Fig. 1) .
The 50 outpatients in study 3 comprised 37 females and 13 males with a mean age of 60 yr and disease duration of 12 yr. They had moderate inflammatory activity measured objectively and reported subjectively (Table I ). The following results apply to patients in study 3 .
In 58% of patients CRP levels were not quantified more accurately than < 10 mg/1. Local laboratories are unable to quantify CRP below 10 mg/1 even though such levels may indicate considerable inflammatory activity. Attention was therefore focused on PV as being the next most reliable indicator of active inflammation, where 64% of patients had levels > 1.72 mPas.
Please indicate whether the symptoms you have had in each joint over the LAST 24 HOURS is none (0), mild (1), moderate (2) 
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All patients reported some symptoms. Stiffness was the most frequently reported symptom (47% of all possible occasions) followed by pain (41%) with swelling and heat less often reported (34 and 26%). Symptoms were reported most frequently in the wrists (pain 67%, stiffness 66%, swelling 52%, heat 40%) and ankles (61, 55, 51 and 33%) whilst the least troublesome joints were the jaws (pain 13%, stiffness 13%, swelling 3%, heat 6%) and hips (24, 21, 8 and 6%) (Fig. 2) .
By selecting only those joints and symptoms included in a TKAI it was possible to compare the clinical research assistant's evaluation of the TKAI and the patients' reports of the same symptoms (pain plus swelling) in the same joints (Fig. 3) . The patients' self-report TKAIs and research assistant's TKAIs correlated at 0.605 (P < 0.001) and scores for individual joints or joint groups also showed significant correlations (Table II) . However patients' scores were often greater than the research assistant's evaluation and the mean difference between them was 45 (S.D. 143.6). Thus, assuming these differences to be normally distributed, approximately 50% of the patients' scores differed from the research assistant's by at least 97 units. Neither the patients' self-report TKAI nor the health care professional's TKAI correlated with PV (r = 0.04 and 0.221, respectively).
The relationship between each symptom and PV was initially assessed using univariate correlation coefficients. The left and right scores for each joint were added, producing a set of scores for each symptom in every joint. The DIPs were added and treated as a single unit, as were the PIPs, MCPs, MTPs and toes. Although PV was normally distributed, the symptom scores had a high degree of positive skewness, thus Spearman's rank correlation was used. The correlations are shown in Table III significantly different from zero at the 5% level but with correction for 54 correlation coefficients from 49 individuals only correlations of a magnitude of 0.485 or greater should be considered significant. Only two correlations were greater than 0.282 and none were greater than 0.458. Therefore there is no evidence to suggest that a patient assessment of joint symptoms could predict PV levels.
However, in order to assess if a combination of joints could predict PV, multiple regression was also used. Two methods were employed: stepwise regression and best subsets. The former revealed little more than the simple correlations described above. The only combinations found to be significantly related to PV were heat in the DIPs and MTPs, with the MTPs being negatively related.
The best subsets method was used to search through all models of a given size for each symptom and select the 'best' one, based on the R 2 value. Mallow's C p was then used to select the most appropriately sized model for each symptom. Each 'best' model included a different selection of joints. The R 2 values for the 'best' models were 38.5% (heat), 25.5% (pain), 17.2% (stiffness) and 13.1% (swelling). Again some of the joint scores included in these models were negatively related to PV.
In study 4 each of these four 'best' models was used to predict PV in a further group of 11 in-patients admitted during an exacerbation of their disease, who had higher levels of inflammatory activity than the outpatient group (Table I) . The actual and predicted PV values are shown in Table IV . No model was considered to be adequate for PV prediction.
There was no significant correlation between PV and patient's VAS of pain or perceived disease activity for either the out-patients in study 3 (pain r =0.116, perceived disease activity r = 0.032) or the in-patients in study 4 experiencing a flare (pain r = 0.247, perceived disease activity r = 0.029).
DISCUSSION
It might have been expected that patients, particularly those with several years experience of fluctuating joint inflammation, would be able to accurately report evidence of inflammatory activity and thus our aim was to develop an SRAI which reflected such activity by correlation with the acute phase response. It has not been possible to do so. Information on inflammatory activity provided by the clinician's TKAI which has been shown to correlate with the acute phase response [5] cannot be replaced by reliance on either a compilation of patient's reports of symptoms, or a VAS for pain or perceived disease activity. It is possible that the number of patients with relatively little inflammatory activity (as indicated by CRP and PV levels) made this an unsuitable data set with which to attempt to construct a joint inflammation measurement tool. However, any such tool must identify not only those patients with inflammatory activity, but also those without. In addition the only possible models constructed with any likelihood of success fared no better using a set of in-patients with considerable inflammatory activity.
This study used a very short time-frame for reported symptoms (24 h) as opposed to Mason et al. [6] who used a 6-month time-frame. It was anticipated that this would give greater correlation with current laboratory measures of inflammation, enhanced by the fact that patients would not have to 'average out' their symptoms over a long time period. However, neither ourselves nor Stewart et al. [7] (who also used this short time-frame) were able to produce an SRAI which adequately reflected inflammatory activity.
Patients clearly experience multiple symptoms (heat, pain, stiffness and swelling) in multiple joints and are able to both distinguish and record the different symptoms and their severity in individual joints. Surprisingly, stiffness rather than pain was the most frequently reported joint symptom, particularly in the small joints of the hands and feet. It is possible that stiffness causes more difficulty than pain in performing fine movements and that this awareness leads to greater reporting of stiffness. However, health care professionals often ask about overall morning stiffness and rarely about stiffness in individual joints, apparently a common problem for patients.
The aim of this study was to develop an SRAI which correlates with the acute phase response but the design of the study also enabled us to compare the research assistant's TKAI with a patient self-report TKAI. The moderate correlation between these (r = 0.605) should not be over-interpreted as the variations between the researcher's and patients' scores vary widely. The correlation mirrors that found elsewhere (r = 0.53) [7] and is not unexpected as similar features of arthritis are being recorded, albeit from different perspectives. The TKAI was developed to reflect inflammatory activity by correlation with CRP and although this is not ideal as 0.65, is the best out of all available AIs [5] . It does not appear to correlate well with other inflammatory indices as indicated by the poor correlations with PV in this study and ESR in Stewart et a/.'s study [7] . In common clinical practice the clinician still requires the information from the TKAI to be supported by laboratory measures of inflammation for that patient. The patient self-report TKAI did not correlate at all with laboratory measures of inflammatory activity either in this study (using PV, r = 0.04) or Stewart's study (using CRP, r = 0.25) [7] and thus clearly cannot be used as a surrogate for measuring the acute phase response.
Thus two comprehensive studies have shown that whilst patients can complete a self-report TKAI in a way that moderately correlates with a clinician's opinion, we cannot use this tool to adequately report inflammatory activity by correlation with the acute phase response (the aim of this study). In addition, the current study which attempts to develop such an SRAI without any prior assumptions as to joints, signs, symptoms or gradings (rather than utilizing the existing Al such as the TKAI) could not develop an adequate self-report tool for inflammatory activity. If clinician's are tempted to use an SRAI such as the TKAI they must be aware that this will not reliably indicate inflammatory activity.
The SRAI however, should not be dismissed altogether. Patients are clearly able to differentiate and report various joint signs and symptoms at different levels. Further work needs to be carried out to explore the significance of these reports and whether they are sensitive to treatment changes, or fluctuations in psychological status or pain, in which case they may well be a valuable contribution to our assessment of the patient.
The nature of the information provided by an SRAI needs to be more precisely established before it can be used as an assessment tool in its own right. It should not be used merely because it moderately correlates with the TKAI which was designed as a measure of inflammatory activity, when it has been shown that the SRAI does not, in itself, correlate with the acute phase response.
